Dr. Joanna Greenwood Joins Applied DNA Sciences as Technical Director, EMEA

Dr. Joanna Greenwood, who is well known and respected throughout the UK and European Forensic taggant industry for her extensive knowledge, experience and integrity, has joined APDN as Technical Director, EMEA.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Having Jo on board will bring significant benefits to our EMEA clients and our operations in the support of our growth plans, current technology and perhaps more importantly the development of new and improved products.

Stony Brook, NY (PRWEB) May 01, 2014

Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a biotech firm that provides DNA-based authentication and security solutions, announced today the appointment of a new member of its Europe, Middle East and Africa (EMEA) team. Dr. Joanna Greenwood, who is well known and respected throughout the United Kingdom and European Forensic taggant industry for her extensive knowledge, experience and integrity, has joined APDN as Technical Director, EMEA.

Dr. Greenwood holds a Ph.D. in Earth Sciences from Cambridge University in England and a B.Sc. with first class honours from Durham University as well as having a plethora of research publications to her name. Jo previously served at SmartWater Technology Limited, rising to the position of Director of Technical Services.

Her experience notably includes:

  • Over 16 years of expertise in analytical chemistry techniques, specializing in the detection of trace elements
  • The development and validation of new methods of analysis and sample preparation
  • Expertise in the field of data interpretation especially as it relates to trace evidence
  • Management of ISO/IEC 17025 accredited laboratories
  • Quality control analysis and quality management systems
  • Extensive experience in law courts as an expert witness, and,
  • Technical author of a British Standards Institute

On joining APDN, Dr. Greenwood commented, "I am very much looking forward to working with the Applied DNA Sciences EMEA team, supporting new and existing clients in their use of APDN's ground-breaking forensic solutions to combat criminal activity. The opportunity to be part of an organization with such a strong emphasis on innovation and bringing new, technologically advanced, products to market, is particularly exciting."

Tony Benson, Managing Director for EMEA said, "Having Jo on board will bring significant benefits to our EMEA clients as we expand operationally in the region with a broader technology solution set and the laboratory and forensic services that provide the full backstop of assurance for our customers. I have no doubt that Jo will both enjoy the role and excel in her new environment at APDN where our people are recognized as our most valuable assets."

Dr. James Hayward, CEO of Applied DNA Sciences, stated, "Jo's scientific and business acumen fit perfectly with our technology and business road maps. Her experience will help us make the world a better, more authentic place."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our antitheft product, SigNature T®, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2013 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


Contact